Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katja de With

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
The Journal of Antimicrobial Chemotherapy|November 2, 2017
Validation of adapted daily dose definitions for hospital antibacterial drug use evaluation: a multicentre studyGesche Först, Katja de With, Nadine Weber, et al.
The Journal of Antimicrobial Chemotherapy|September 11, 2019
Clinimetric properties and suitability of selected quality indicators for assessing antibiotic use in hospitalized adults: a multicentre point prevalence study in 24 hospitals in GermanyGesche Först, Winfried V Kern, Nadine Weber, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|August 19, 2020
Universal laboratory testing for SARS-CoV-2 in hyperacute stroke during the COVID-19 pandemicKristian Barlinn, Timo Siepmann, Lars-Peder Pallesen, et al.
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen|February 8, 2023
[Development and validation of potential structure indicators for clinical infectious disease (ID) care in German hospitals during the COVID-19 pandemic]Lene Tscharntke, Melanie Stecher, Annika Y Classen, et al.
Infection|March 15, 2017
The "Choosing Wisely" initiative in infectious diseasesClara Lehmann, Reinhard Berner, Johannes R Bogner, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 9, 2025
Establishing Core Competencies for Antimicrobial Stewardship Teams: A Consensus Development Using the Modified Delphi Technique; an ESGAP position paperJoana Alves, Jeroen Schouten, Karin Thursky, et al.
Open Forum Infectious Diseases|January 5, 2024
Absence of Type I Interferon Autoantibodies or Significant Interferon Signature Alterations in Adults With Post-COVID-19 SyndromeMartin Achleitner, Nina K Mair, Juliane Dänhardt, et al.
Deutsches Arzteblatt International|June 28, 2021
Risk Factors for a Severe Course of COVID-19 in Persons Aged 18 to 61Johannes Schetelig, Henning Baldauf, Sarah Wendler, et al.
Journal of Neurology|August 8, 2020
Association of history of cerebrovascular disease with severity of COVID-19Timo Siepmann, Annahita Sedghi, Jessica Barlinn, et al.
Frontiers in Immunology|August 12, 2021
Individual <i>HLA-A, -B, -C</i>, and <i>-DRB1</i> Genotypes Are No Major Factors Which Determine COVID-19 SeverityJohannes Schetelig, Falk Heidenreich, Henning Baldauf, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
The Journal of Antimicrobial Chemotherapy|November 2, 2017
Validation of adapted daily dose definitions for hospital antibacterial drug use evaluation: a multicentre studyGesche Först, Katja de With, Nadine Weber, et al.
The Journal of Antimicrobial Chemotherapy|September 11, 2019
Clinimetric properties and suitability of selected quality indicators for assessing antibiotic use in hospitalized adults: a multicentre point prevalence study in 24 hospitals in GermanyGesche Först, Winfried V Kern, Nadine Weber, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|August 19, 2020
Universal laboratory testing for SARS-CoV-2 in hyperacute stroke during the COVID-19 pandemicKristian Barlinn, Timo Siepmann, Lars-Peder Pallesen, et al.
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen|February 8, 2023
[Development and validation of potential structure indicators for clinical infectious disease (ID) care in German hospitals during the COVID-19 pandemic]Lene Tscharntke, Melanie Stecher, Annika Y Classen, et al.
Infection|March 15, 2017
The "Choosing Wisely" initiative in infectious diseasesClara Lehmann, Reinhard Berner, Johannes R Bogner, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 9, 2025
Establishing Core Competencies for Antimicrobial Stewardship Teams: A Consensus Development Using the Modified Delphi Technique; an ESGAP position paperJoana Alves, Jeroen Schouten, Karin Thursky, et al.
Open Forum Infectious Diseases|January 5, 2024
Absence of Type I Interferon Autoantibodies or Significant Interferon Signature Alterations in Adults With Post-COVID-19 SyndromeMartin Achleitner, Nina K Mair, Juliane Dänhardt, et al.
Deutsches Arzteblatt International|June 28, 2021
Risk Factors for a Severe Course of COVID-19 in Persons Aged 18 to 61Johannes Schetelig, Henning Baldauf, Sarah Wendler, et al.
Journal of Neurology|August 8, 2020
Association of history of cerebrovascular disease with severity of COVID-19Timo Siepmann, Annahita Sedghi, Jessica Barlinn, et al.
Frontiers in Immunology|August 12, 2021
Individual <i>HLA-A, -B, -C</i>, and <i>-DRB1</i> Genotypes Are No Major Factors Which Determine COVID-19 SeverityJohannes Schetelig, Falk Heidenreich, Henning Baldauf, et al.
Pageof 6